Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China

World Journal of Gastroenterology

Volumn 22, Issue 8, 2016, Pages 2601-2610

  Hu, Hai Jie ^a   Mao, Hui ^a   Shrestha, Anuj ^a,b   Tan, Yong Qiong ^a   Ma, Wen Jie ^a   Yang, Qin ^a   Wang, Jun Ke ^a   Cheng, Nan Sheng ^a   Li, Fu Yu ^a  

^a SICHUAN UNIVERSITY   (China)

^b Gandaki Medical College   (Nepal)

Author keywords

Hilar cholangiocarcinoma; Prognosis; Surgical outcome; Survival; Tumor free margin

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; BILE DUCT CARCINOMA; BILE LEAKAGE; BILIARY TRACT SURGERY; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CHINA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HYDROTHORAX; HYPERBILIRUBINEMIA; KIDNEY FAILURE; LIVER FAILURE; LOBECTOMY; LUNG INFECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OPERATIVE BLOOD LOSS; OVERALL SURVIVAL; PALLIATIVE THERAPY; PERITONITIS; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; SEPSIS; STRESS ULCER; SURGICAL INFECTION; TUMOR INVASION; VERY ELDERLY; WOUND DEHISCENCE; ADVERSE EFFECTS; BILE DUCT NEOPLASMS; CELL DIFFERENTIATION; CHI SQUARE DISTRIBUTION; FACTUAL DATABASE; KAPLAN MEIER METHOD; KLATSKIN TUMOR; LIVER RESECTION; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MORTALITY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOLOGY; PATIENT SELECTION; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILIARY TRACT SURGICAL PROCEDURES; CELL DIFFERENTIATION; CHI-SQUARE DISTRIBUTION; CHINA; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; KLATSKIN TUMOR; LOGISTIC MODELS; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; ODDS RATIO; PALLIATIVE CARE; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84959894830     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i8.2601     Document Type: Article

References (45)

1. Baton O, Azoulay D, Adam DV, Castaing D. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg 2007; 204: 250-260 [PMID: 17254929 DOI: 10.1016/j.jamcollsurg.2006.10.028]
2. Xiong J, Nunes QM, Huang W, Wei A, Ke N, Mai G, Liu X, Hu W. Major hepatectomy in Bismuth types I and II hilar cholangiocarcinoma. J Surg Res 2015; 194: 194-201 [PMID: 25454973 DOI: 10.1016/j.jss.2014.10.029]
3. Figueras J, Codina-Barreras A, López-Ben S, Soriano J, Pardina B, Falgueras L, Castro E, Torres-Bahi S, Ortiz R, Diaz E, Maroto A, Canals E. [Major hepatectomies are safe in patients with cholangiocarcinoma and jaundice]. Cir Esp 2009; 86: 296-302 [PMID: 19646686 DOI: 10.1016/s2173-5077(09)70100-0]
4. Saxena A, Chua TC, Chu FC, Morris DL. Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Am J Surg 2011; 202: 310-320 [PMID: 21871986 DOI: 10.1016/j.amjsurg.2010.08.041]
5. D'Angelica MI, Jarnagin WR, Blumgart LH. Resectable hilar cholangiocarcinoma: surgical treatment and long-term outcome. Surg Today 2004; 34: 885-890 [PMID: 15526120 DOI: 10.1007/s00595-004-2832-3]
6. Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 2008; 10: 77-82 [PMID: 18773060 DOI: 10.1080/1365182080199 2641]
7. Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, Makuuchi M. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003; 238: 73-83 [PMID: 12832968 DOI: 10.1097/01. SLA.0000074960.55004.72]
8. Lillemoe KD, Cameron JL. Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach. J Hepatobiliary Pancreat Surg 2000; 7: 115-121 [PMID: 10982602 DOI: 10.1007/s005340000070115.534]
9. Rea DJ, Munoz-Juarez M, Farnell MB, Donohue JH, Que FG, Crownhart B, Larson D, Nagorney DM. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg 2004; 139: 514-523; discussion 523-525 [PMID: 15136352 DOI: 10.1001/archsurg.139.5.514]
10. Gerhards MF, van Gulik TM, Bosma A, ten Hoopen-Neumann H, Verbeek PC, Gonzalez Gonzalez D, de Wit LT, Gouma DJ. Long-term survival after resection of proximal bile duct carcinoma (Klatskin tumors). World J Surg 1999; 23: 91-96 [PMID: 9841770]
11. Lee SG, Lee YJ, Park KM, Hwang S, Min PC. One hundred and eleven liver resections for hilar bile duct cancer. J Hepatobiliary Pancreat Surg 2000; 7: 135-141 [PMID: 10982605 DOI: 10.1007/s005340000070135.534]
12. Tsao JI, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M, Miyachi M, Kanai M, Uesaka K, Oda K, Rossi RL, Braasch JW, Dugan JM. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg 2000; 232: 166-174 [PMID: 10903592]
13. Gazzaniga GM, Filauro M, Bagarolo C, Mori L. Surgery for hilar cholangiocarcinoma: an Italian experience. J Hepatobiliary Pancreat Surg 2000; 7: 122-127 [PMID: 10982603 DOI: 10.1007/s005340000070122.534]
14. Yi B, Xu AM, Lai EC, Qu ZQ, Cheng QB, Liu C, Luo XJ, Yu Y, Qiu YH, Wang XY, Cheng HY, Zhang BH, Shen F, Lau WY, Wu MC, Jiang XQ. Preoperative portal vein embolization for hilar cholangiocarcinoma-a comparative study. Hepatogastroenterology 2010; 57: 1341-1346 [PMID: 21443082]
15. Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH. Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998; 228: 385-394 [PMID: 9742921]
16. Qiu ZQ, Tan WF, Yan PN, Luo XJ, Zhang BH, Wu MC, Jiang XQ, Lau WY. Early control of short hepatic portal veins in isolated or combined hepatic caudate lobectomy. Hepatobiliary Pancreat Dis Int 2012; 11: 377-382 [PMID: 22893464 DOI: 10.1016/s1499-3872(12)60195-7]
17. Ahanatha Pillai S, Sathyanesan J, Perumal S, Ulagendra Perumal S, Lakshmanan A, Ramaswami S, Ramasamy R, Palaniappan R, Rajagopal S. Isolated caudate lobe resection: technical challenges. Ann Gastroenterol 2013; 26: 150-155 [PMID: 24714918]
18. Sakoda M, Ueno S, Kubo F, Hiwatashi K, Tateno T, Kurahara H, Mataki Y, Shinchi H, Natsugoe S. Surgery for hepatocellular carcinoma located in the caudate lobe. World J Surg 2009; 33: 1922-1926 [PMID: 19582505 DOI: 10.1007/s00268-009-0110-7]
19. Abdel Wahab M, Lawal AR, EL Hanafy E, Salah T, Hamdy E, Sultan AM. Caudate lobe resection: an Egyptian center experience. Langenbecks Arch Surg 2009; 394: 1057-1063 [PMID: 19763602 DOI: 10.1007/s00423-009-0554-0]
20. Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K, Matsumoto J, Kawasaki R. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Sci 2010; 17: 455-462 [PMID: 19820891 DOI: 10.1007/s00534-009-0208-1]
21. Ramacciato G, Nigri G, Bellagamba R, Petrucciani N, Ravaioli M, Cescon M, Del Gaudio M, Ercolani G, Di Benedetto F, Cautero N, Quintini C, Cucchetti A, Lauro A, Miller C, Pinna AD. Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinoma. Am Surg 2010; 76: 1260-1268 [PMID: 21140696]
22. Neuhaus P, Jonas S, Settmacher U, Thelen A, Benckert C, Lopez-Hänninen E, Hintze RE. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg 2003; 388: 194-200 [PMID: 12819970 DOI: 10.1007/s00423-003-0383-5]
23. Regimbeau JM, Fuks D, Pessaux P, Bachellier P, Chatelain D, Diouf M, Raventos A, Mantion G, Gigot JF, Chiche L, Pascal G, Azoulay D, Laurent A, Letoublon C, Boleslawski E, Rivoire M, Mabrut JY, Adham M, Le Treut YP, Delpero JR, Navarro F, Ayav A, Boudjema K, Nuzzo G, Scotte M, Farges O. Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 group. HPB (Oxford) 2015; 17: 79-86 [PMID: 24992279 DOI: 10.1111/hpb.12296]
24. Miyazawa M, Toshimitsu Y, Torii T, Okada K, Koyama I. Extended right hepatectomy for hilar cholangiocarcinoma with resection of the left hepatic duct prior to hepatic resection. J Surg Oncol 2006; 93: 72-75 [PMID: 16353189 DOI: 10.1002/jso.20401]
25. Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Nozawa S, Furukawa K, Mitsuhashi N, Takeuchi D, Suda K, Yoshioka I. Recent advance in the treatment of hilar cholangiocarcinoma: hepatectomy with vascular resection. J Hepatobiliary Pancreat Surg 2007; 14: 463-468 [PMID: 17909714 DOI: 10.1007/s00534-006-1195-0]
26. Kow AW, Wook CD, Song SC, Kim WS, Kim MJ, Park HJ, Heo JS, Choi SH. Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution. World J Surg 2012; 36: 1112-1121 [PMID: 22374541 DOI: 10.1007/s00268-012-1497-0]
27. Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 1997; 79: 26-34 [PMID: 8988723 DOI: 10.1002/(Sici)1097-0142(19970101)79]
28. Li H, Qin Y, Cui Y, Chen H, Hao X, Li Q. Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience. Dig Surg 2011; 28: 226-231 [PMID: 21540611 DOI: 10.1159/000327361]
29. Dumitrascu T, Chirita D, Ionescu M, Popescu I. Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome. J Gastrointest Surg 2013; 17: 913-924 [PMID: 23319395 DOI: 10.1007/s11605-013-2144-2]
30. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS J, Youssef BA M, Klimstra D, Blumgart LH. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234: 507-17; discussion 517-9 [PMID: 11573044]
31. Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, Rikkers LF, Weber SM. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg 2008; 248: 273-279 [PMID: 18650638 DOI: 10.1097/SLA.0b013e31817f2bfd]
32. Igami T, Nishio H, Ebata T, Yokoyama Y, Sugawara G, Nimura Y, Nagino M. Surgical treatment of hilar cholangiocarcinoma in the new era: the Nagoya University experience. J Hepatobiliary Pancreat Sci 2010; 17: 449-454 [PMID: 19806294 DOI: 10.1007/s00534-009-0209-0]
33. Ercolani G, Zanello M, Grazi GL, Cescon M, Ravaioli M, Del Gaudio M, Vetrone G, Cucchetti A, Brandi G, Ramacciato G, Pinna AD. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center. J Hepatobiliary Pancreat Sci 2010; 17: 329-337 [PMID: 20464563 DOI: 10.1007/s00534-009-0249-5]
34. Sano T, Shimada K, Sakamoto Y, Yamamoto J, Yamasaki S, Kosuge T. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg 2006; 244: 240-247 [PMID: 16858186 DOI: 10.1097/01. sla.0000217605.66519.38]
35. Matsuo K, Rocha FG, Ito K, D'Angelica MI, Allen PJ, Fong Y, Dematteo RP, Gonen M, Endo I, Jarnagin WR. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg 2012; 215: 343-355 [PMID: 22749003 DOI: 10.1016/j.jamcollsurg.2012. 05.025]
36. Ruys AT, van Haelst S, Busch OR, Rauws EA, Gouma DJ, van Gulik TM. Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg 2012; 36: 2179-2186 [PMID: 22569746 DOI: 10.1007/s00268-012-1638-5]
37. Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 2003; 238: 720-727 [PMID: 14578735 DOI: 10.1097/01. sla.0000094437.68038.a3]
38. Lee SG, Song GW, Hwang S, Ha TY, Moon DB, Jung DH, Kim KH, Ahn CS, Kim MH, Lee SK, Sung KB, Ko GY. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Sci 2010; 17: 476-489 [PMID: 19851704 DOI: 10.1007/s00534-009-0204-5]
39. Nuzzo G, Giuliante F, Ardito F, Giovannini I, Aldrighetti L, Belli G, Bresadola F, Calise F, Dalla Valle R, D'Amico DF, Gennari L, Giulini SM, Guglielmi A, Jovine E, Pellicci R, Pernthaler H, Pinna AD, Puleo S, Torzilli G, Capussotti L, Cillo U, Ercolani G, Ferrucci M, Mastrangelo L, Portolani N, Pulitanò C, Ribero D, Ruzzenente A, Scuderi V, Federico B. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg 2012; 147: 26-34 [PMID: 22250108 DOI: 10.1001/archsurg.2011.771]
40. Kobayashi A, Miwa S, Nakata T, Miyagawa S. Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg 2010; 97: 56-64 [PMID: 19937985 DOI: 10.1002/bjs.6788]
41. DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007; 245: 755-762 [PMID: 17457168 DOI: 10.1097/01.sla.0000251366.62632.d3]
42. Hasegawa S, Ikai I, Fujii H, Hatano E, Shimahara Y. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg 2007; 31: 1256-1263 [PMID: 17453285 DOI: 10.1007/s00268-007-9001-y]
43. Dinant S, Gerhards MF, Rauws EA, Busch OR, Gouma DJ, van Gulik TM. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol 2006; 13: 872-880 [PMID: 16614876 DOI: 10.1245/ASO.2006.05.053]
44. Cheng QB, Yi B, Wang JH, Jiang XQ, Luo XJ, Liu C, Ran RZ, Yan PN, Zhang BH. Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV. Eur J Surg Oncol 2012; 38: 1197-1203 [PMID: 22992326 DOI: 10.1016/j.ejso.2012.08.009]
45. Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical management of hilar cholangiocarcinoma. Ann Surg 2005; 241: 693-699; discussion 699-702 [PMID: 15849505 DOI: 10.1097/01. sla.0000160701.38945.82]